Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-06-10 | 2020-09-14 | 117377 |
| APO-CILAZAPRIL | 1MG | TABLET | Resolved | 2017-06-27 | 2017-07-24 | 14068 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2017-07-25 | 2017-08-15 | 16853 |
| APO-CILAZAPRIL | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 80 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2021-12-24 | 2022-04-04 | 151883 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2018-01-03 | 2018-08-18 | 34841 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 83 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2023-11-24 | 2023-12-01 | 211496 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2022-12-05 | 2023-02-02 | 177115 |
| APO-CIMETIDINE ORAL SOLUTION | 300MG | LIQUID | Actual shortage | 2017-08-13 | 2017-10-05 | 19102 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218382 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2024-02-23 | 2024-03-22 | 220447 |
| APO-CINACALCET | 90MG | TABLET | Resolved | 2018-05-08 | 2018-11-23 | 48835 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2018-08-09 | 2018-11-23 | 57775 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2020-10-14 | 2020-12-21 | 126274 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2020-10-28 | 2020-12-21 | 127331 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2021-02-26 | 2021-03-24 | 134802 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2023-01-13 | 2023-01-26 | 181113 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2023-06-02 | 2023-06-16 | 193606 |
| APO-CINACALCET | 90MG | TABLET | Resolved | 2022-09-09 | 2022-10-07 | 169051 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI CAP 250MG | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-AMOXI CAP 500MG | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
| APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
| APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
| APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |